{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:53:57Z","timestamp":1788836037502,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11912-024-01494-w","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T05:02:17Z","timestamp":1706158937000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sarcopenia and Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"26","author":[{"given":"Dominique","family":"Clement","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique V.","family":"Leerdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaventhan","family":"Srirajaskanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"issue":"1","key":"1494_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"\u2022 Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331. (This guideline describes the definition and diagnosis of sarcopenia.)","journal-title":"Age Ageing"},{"issue":"7","key":"1494_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1494_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1017\/S0029665115004279","volume":"75","author":"CM Prado","year":"2016","unstructured":"Prado CM, Cushen SJ, Orsso CE, Ryan AM. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc. 2016;75(2):188\u201398.","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"1494_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"11","key":"1494_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41416-019-0606-3","volume":"121","author":"TSE Genus","year":"2019","unstructured":"Genus TSE, Bouvier C, Wong KF, Srirajaskanthan R, Rous BA, Talbot DC, et al. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013\u20132015. Br J Cancer. 2019;121(11):966\u201372.","journal-title":"Br J Cancer"},{"issue":"5","key":"1494_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MPA.0000000000000818","volume":"46","author":"EM Wolin","year":"2017","unstructured":"Wolin EM, Leyden J, Goldstein G, Kolarova T, Hollander R, Warner RRP. Patient-reported experience of diagnosis, management, and burden of neuroendocrine tumors: results from a large patient survey in the United States. Pancreas. 2017;46(5):639\u201347.","journal-title":"Pancreas"},{"issue":"1","key":"1494_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000488510","volume":"107","author":"R Basuroy","year":"2018","unstructured":"Basuroy R, Bouvier C, Ramage JK, Sissons M, Kent A, Srirajaskanthan R. Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2018;107(1):42\u20139.","journal-title":"Neuroendocrinology."},{"issue":"1","key":"1494_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MITDITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community. Clin Nut. 2019;38(1):1\u20139.","journal-title":"Clin Nut."},{"issue":"2","key":"1494_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4989","volume":"48","author":"H Nishikawa","year":"2021","unstructured":"\u2022 Nishikawa H, Fukunishi S, Asai A, Yokohama K, Nishiguchi S, Higuchi K. Pathophysiology and mechanisms of primary sarcopenia (review). Int J Mol Med. 2021;48(2):1\u20138. (This review summarizes the current evidence regarding pathophysiology of sarcopenia.)","journal-title":"Int J Mol Med"},{"issue":"4","key":"1494_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"9","key":"1494_CR11","first-page":"5760","volume":"9","author":"JA Ligibel","year":"2020","unstructured":"\u2022 Ligibel JA, Schmitz KH, Berger NA, Sciences PH, Sciences G, Comprehensive C, et al. HHS Public Access. 2020;9(9):5760\u201371. (This review summarizes the current evidence regarding pathophysiology of sarcopenia.)","journal-title":"HHS Public Access"},{"issue":"5","key":"1494_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/NCC.0000000000000426","volume":"40","author":"B Pedersen","year":"2017","unstructured":"Pedersen B, Delmar C, Bendtsen MD, Bosaeus I, Carus A, Falkmer U, et al. Changes in weight and body composition among women with breast cancer during and after adjuvant treatment: a prospective follow-up study. Cancer Nurs. 2017;40(5):369\u201376.","journal-title":"Cancer Nurs"},{"issue":"1","key":"1494_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12877-018-1007-9","volume":"18","author":"Y-D Rong","year":"2018","unstructured":"Rong Y-D, Bian A-L, Hu H-Y, Ma Y, Zhou X-Z. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18(1):308.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1494_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","volume":"22","author":"A-L Bian","year":"2017","unstructured":"Bian A-L, Hu H-Y, Rong Y-D, Wang J, Wang J-X, Zhou X-Z. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1. Eur J Med Res. 2017;22(1):25.","journal-title":"Eur J Med Res"},{"key":"1494_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fphys.2018.00409","volume":"9","author":"S P\u00e9rez-Baos","year":"2018","unstructured":"P\u00e9rez-Baos S, Prieto-Potin I, Rom\u00e1n-Blas JA, S\u00e1nchez-Pernaute O, Largo R, Herrero-Beaumont G. Mediators and patterns of muscle loss in chronic systemic inflammation. Front Physiol. 2018;9:409.","journal-title":"Front Physiol"},{"key":"1494_CR16","doi-asserted-by":"crossref","unstructured":"von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1:129\u201333.","DOI":"10.1007\/s13539-010-0014-2"},{"issue":"12","key":"1494_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.14740\/jocmr2361w","volume":"7","author":"H Yanai","year":"2015","unstructured":"Yanai H. Nutrition for sarcopenia. J Clin Med Res. 2015;7(12):926\u201331.","journal-title":"J Clin Med Res"},{"issue":"4","key":"1494_CR18","first-page":"217","volume":"5","author":"M Milione","year":"2019","unstructured":"Milione M, Miceli R, Barretta F, Pellegrinelli A, Spaggiari P, Tagliabue G, et al. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms. J Pathol: Clin Res. 2019;5(4):217\u201326.","journal-title":"J Pathol: Clin Res"},{"issue":"July","key":"1494_CR19","first-page":"1","volume":"12","author":"E Giannetta","year":"2021","unstructured":"Giannetta E, La Salvia A, Rizza L, Muscogiuri G, Campione S, Pozza C, et al. Are markers of systemic inflammatory response useful in the management of patients with neuroendocrine neoplasms? Front Endocrinol. 2021;12(July):1\u201315.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1494_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755\u201363.","journal-title":"Am J Epidemiol"},{"key":"1494_CR21","doi-asserted-by":"crossref","unstructured":"Shepherd J, Ng B, Sommer M, Heymsfield SB, Francisco S. HHS public access \u201cbody composition by DXA.\u201d\u00a0Bone. 2017;104:101\u20135.","DOI":"10.1016\/j.bone.2017.06.010"},{"issue":"2","key":"1494_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ajcn\/76.2.378","volume":"76","author":"J Kim","year":"2002","unstructured":"Kim J, Wang ZM, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002;76(2):378\u201383.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1494_CR23","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.3390\/s140610895","volume":"14","author":"SF Khalil","year":"2014","unstructured":"Khalil SF, Mohktar MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors. 2014;14(6):10895\u2013928.","journal-title":"Sensors"},{"issue":"6","key":"1494_CR24","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97(6):2333\u20138.","journal-title":"J Appl Physiol"},{"key":"1494_CR25","unstructured":"Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, Mccargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care."},{"key":"1494_CR26","doi-asserted-by":"crossref","unstructured":"Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","DOI":"10.1200\/JCO.2012.45.2722"},{"key":"1494_CR27","doi-asserted-by":"crossref","unstructured":"Trejo-Avila M, Bozada-Guti\u00e9rrez K, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Color Dis. 2021;36(6):1077\u201396.","DOI":"10.1007\/s00384-021-03839-4"},{"key":"1494_CR28","doi-asserted-by":"publisher","first-page":"111156","DOI":"10.1016\/j.nut.2021.111156","volume":"86","author":"DD Huang","year":"2021","unstructured":"Huang DD, Cai HY, Wang WB, Song HN, Luo X, Dong WX, et al. Measurement of muscle quantity\/quality has additional predictive value for postoperative complications and long-term survival after gastrectomy for gastric cancer in patients with probable sarcopenia as defined by the new EWGSOP2 consensus: Analysis from. Nutrition. 2021;86:111156.","journal-title":"Nutrition."},{"key":"1494_CR29","doi-asserted-by":"crossref","unstructured":"Sandini M, Bernasconi DP, Fior D, Molinelli M, Ippolito D, Nespoli L, et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32:1231\u201337.","DOI":"10.1016\/j.nut.2016.04.002"},{"key":"1494_CR30","doi-asserted-by":"crossref","unstructured":"Boer BC, de Graaff F, Brusse-Keizer M, Bouman DE, Slump CH, Slee-Valentijn M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis. 2016;31:1117\u201324.","DOI":"10.1007\/s00384-016-2538-1"},{"key":"1494_CR31","doi-asserted-by":"crossref","unstructured":"Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, et al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer. 2014;66(4):583\u201389.","DOI":"10.1080\/01635581.2014.894103"},{"key":"1494_CR32","doi-asserted-by":"crossref","unstructured":"Tan BHL, Brammer K, Randhawa N, Welch NT, Parsons SL, James EJ, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Europ J Surg Oncol. 2015;41:333\u20138.","DOI":"10.1016\/j.ejso.2014.11.040"},{"key":"1494_CR33","doi-asserted-by":"crossref","unstructured":"Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MPC, et al. Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer. J Gastric Cancer. 2017;17(1):74\u201387.","DOI":"10.5230\/jgc.2017.17.e8"},{"key":"1494_CR34","doi-asserted-by":"crossref","unstructured":"Van Vugt JLA, Buettner S, Levolger S, Coebergh Van Den Braak RRJ, Suker M, Gaspersz MP, et al. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. PLoS ONE. 2017;12(10):e0186547","DOI":"10.1371\/journal.pone.0186547"},{"key":"1494_CR35","doi-asserted-by":"crossref","unstructured":"Aahlin EK, Tran\u00f8 G, Johns N, Horn A, S\u00f8reide JA, Fearon KC, et al. Health-related quality of life, cachexia and overall survival after major upper abdominal surgery: a prospective cohort study. Scand J Surg. 2017;106(1):40\u20136.","DOI":"10.1177\/1457496916645962"},{"key":"1494_CR36","doi-asserted-by":"crossref","unstructured":"Nipp RD, Fuchs G, El\u2010Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist.\u00a02018;23:97\u2013104.","DOI":"10.1634\/theoncologist.2017-0255"},{"key":"1494_CR37","doi-asserted-by":"crossref","unstructured":"Zou H-B, Yan X-L, Dong W-X, Yu D-Y, Zhang F-M, Zhou L-P, et al. Sarcopenia is a predictive factor of poor quality of life and prognosis in patients after radical gastrectomy. Europ J Surg Oncol. 2021;47(8):1976\u201384.","DOI":"10.1016\/j.ejso.2021.03.004"},{"issue":"9","key":"1494_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/ejcn.2016.40","volume":"70","author":"A Lind","year":"2016","unstructured":"Lind A, W\u00e4ngberg B, Elleg\u00e5rd L. Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET). Eur J Clin Nutr. 2016;70(9):990\u20134.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"1494_CR39","first-page":"1","volume":"110","author":"T Whyand","year":"2020","unstructured":"Whyand T, Chotai de Lima YCM. Sarcopenia: don\u2019t judge a book by it\u2019s cover. Neuroendocrinol. 2020;110(1):1\u2013312.","journal-title":"Neuroendocrinol."},{"key":"1494_CR40","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Herrera-Mart\u00ednez Y, Teomiro CA, Idougourram SL, Puertas MJM, Continente AC, Blanch RS, et al. Sarcopenia and ghrelin system in the clinical outcome and prognosis of gastroenteropancreatic neuroendocrine neoplasms. Cancers. 2022;14(1):111. (The authors explore the prevalence of sarcopenia at diagnosis of a GEP-NET and association with overall survival and ghrelin system.)","DOI":"10.3390\/cancers14010111"},{"issue":"1","key":"1494_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41430-021-00915-4","volume":"76","author":"DL Chan","year":"2022","unstructured":"\u2022\u2022 Chan DL, Clarke SJ, Engel A, Diakos CI, Pavlakis N, Roach PJ, et al. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT). Eur J Clin Nutr. 2022;76(1):143\u20139. (The authors explore the prevalence of sarcopenia in patients with NENs and treatment with PRRT, interesting prior to PRRT and following a complete course of PRRT.)","journal-title":"Eur J Clin Nutr"},{"key":"1494_CR42","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Clement DSVM, Leerdam ME va., de Jong S, Weickert MO, Ramage JK, Tesselaar MET, et al. Prevalence of sarcopenia and impact on survival in patients with metastatic gastroenteropancreatic neuroendocrine tumours. Cancers. 2023;15(3):782. (The authors explored the prevalence of sarcopenia in patients with a recent diagnosis of a GEP-NET and associate this with overall survival.)","DOI":"10.3390\/cancers15030782"},{"issue":"1","key":"1494_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07506-9","volume":"20","author":"JB Wang","year":"2020","unstructured":"Wang JB, Xue Z, Lu J, He QL, Zheng ZF, Xu BB, et al. Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series. BMC Cancer. 2020;20(1):1\u201313.","journal-title":"BMC Cancer."},{"key":"1494_CR44","doi-asserted-by":"crossref","unstructured":"Jia J, Zeng X, Li C, Yang L, Huang Y, Tong X, et al. A Combination of preoperative computed tomography-defined sarcopenia and systemic inflammation on survival in patients with poorly differentiated neuroendocrine neoplasms following radical resection. Nutr Cancer. 2022;0(0):1\u201311.","DOI":"10.1080\/01635581.2022.2102660"},{"key":"1494_CR45","doi-asserted-by":"crossref","unstructured":"Peterson SJ, Mozer M. Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32:30\u20139.","DOI":"10.1177\/0884533616680354"},{"key":"1494_CR46","doi-asserted-by":"crossref","unstructured":"Calvani R, Picca A, Coelho-J\u00fanior HJ, Tosato M, Marzetti E, Landi F. Diet for the prevention and management of sarcopenia. Metabolism: Clin Exp. 2023;146:155637.","DOI":"10.1016\/j.metabol.2023.155637"},{"issue":"1","key":"1494_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11010136","volume":"11","author":"RH Mellen","year":"2023","unstructured":"\u2022\u2022 Mellen RH, Girotto OS, Marques EB, Laurindo LF, Grippa PC, Mendes CG, et al. Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines. 2023;11(1):1\u201328. (This review summarizes all available evidence regarding nutrition and drug treatment of sarcopenia.)","journal-title":"Biomedicines"},{"issue":"January","key":"1494_CR48","first-page":"1","volume":"7","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Nichetti M, Peroni G, Faliva MA, Naso M, Gasparri C, et al. Where to find leucine in food and how to feed elderly with sarcopenia in order to counteract loss of muscle mass: practical advice. Front Nutr. 2021;7(January):1\u20139.","journal-title":"Front Nutr"},{"issue":"2","key":"1494_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcsm.12525","volume":"11","author":"CM Prado","year":"2020","unstructured":"Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366\u201380.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1494_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11\u201348.","journal-title":"Clin Nutr"},{"issue":"12","key":"1494_CR51","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1210\/jc.2003-030604","volume":"88","author":"M Visser","year":"2003","unstructured":"Visser M, Deeg DJH, Lips P. Low vitamin d and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1494_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/PHM.0000000000001572","volume":"100","author":"F Agostini","year":"2021","unstructured":"Agostini F, Bernetti A, Di Giacomo G, Viva MG, Paoloni M, Mangone M, et al. Rehabilitative good practices in the treatment of sarcopenia. Am J Phys Med Rehabil. 2021;100(3):280\u20137.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1494_CR53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/01635581.2016.1152387","volume":"68","author":"E Motylewska","year":"2016","unstructured":"Motylewska E, Gawronska J, Niedziela A, Melen-Mucha G, Lawnicka H, Komorowski J, et al. Somatostatin analogs and tumor localization do not influence vitamin D concentration in patients with neuroendocrine tumors. Nutr Cancer. 2016;68(3):428\u201334.","journal-title":"Nutr Cancer"},{"issue":"5","key":"1494_CR54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/01635581.2018.1470650","volume":"70","author":"HL Robbins","year":"2018","unstructured":"Robbins HL, Symington M, Mosterman B, Goodby J, Davies L, Dimitriadis GK, et al. Supplementation of vitamin D deficiency in patients with neuroendocrine tumors using over-the-counter vitamin D3 preparations. Nutr Cancer. 2018;70(5):748\u201354.","journal-title":"Nutr Cancer"},{"key":"1494_CR55","doi-asserted-by":"crossref","unstructured":"Massironi S, Zilli A, Bernasconi S, Fanetti I, Cavalcoli F, Ciafardini C, et al. A role for vitamin D in the gastro-entero-pancreatic neuroendocrine neoplasms outcome: report on a series from a single institute. Neuroendocrinology. 2017;105:403\u201311.","DOI":"10.1159\/000456619"},{"issue":"6","key":"1494_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/foods12061218","volume":"12","author":"G Voulgaridou","year":"2023","unstructured":"Voulgaridou G, Papadopoulou SD, Spanoudaki M, Kondyli FS, Alexandropoulou I, Michailidou S, et al. Increasing muscle mass in elders through diet and exercise: a literature review of recent RCTs. Foods. 2023;12(6):1\u201325.","journal-title":"Foods"},{"issue":"2","key":"1494_CR57","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.1097\/NCC.0000000000000957","volume":"46","author":"MK Jang","year":"2023","unstructured":"Jang MK, Park C, Tussing-Humphreys L, Fernhall B, Phillips S, Doorenbos AZ. The effectiveness of sarcopenia interventions for cancer patients receiving chemotherapy: a systematic review and meta-analysis. Cancer Nurs. 2023;46(2):E81-90.","journal-title":"Cancer Nurs"},{"issue":"4","key":"1494_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11605-017-3618-4","volume":"22","author":"JM Cloyd","year":"2018","unstructured":"Cloyd JM, Nogueras-Gonz\u00e1lez GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, et al. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy. J Gastrointest Surg. 2018;22(4):703\u201312.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"1494_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-07868-8","volume":"21","author":"K Baeg","year":"2021","unstructured":"Baeg K, Harris C, Naparst MS, Ahn E, Thapi S, Martin J, et al. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients. BMC Cancer. 2021;21(1):1\u20137.","journal-title":"BMC Cancer"},{"key":"1494_CR60","doi-asserted-by":"crossref","unstructured":"Brown JC, Caan BJ, Feliciano EMC, Xiao J, Weltzien E, Prado CM, et al. Weight stability masks changes in body composition in colorectal cancer\u202f: a retrospective cohort study. 2021;113(6):1482\u201389.","DOI":"10.1093\/ajcn\/nqaa440"},{"issue":"1","key":"1494_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-3022-6","volume":"17","author":"M Miyake","year":"2017","unstructured":"Miyake M, Morizawa Y, Hori S, Marugami N, Shimada K, Gotoh D, et al. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer. 2017;17(1):1\u201311.","journal-title":"BMC Cancer"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-024-01494-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T13:37:35Z","timestamp":1708954655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-024-01494-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s11912-024-01494-w","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"3 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr Dominique Clement, Dr Sarah Brown, Prof Monique v. Leerdam, Dr Margot Tesselaar, Prof John Ramage, declare no conflict of interest. Dr Rajaventhan Srirajaskanthan received research grants from AAA, Ipsen and Novartis, participated in the research board of AAA, Ipsen and Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animal subjects performed by any of the authors. This article only contains human studies previously published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}